Key result
Oral anticoagulation, including warfarin and new oral anticoagulants, offers significant protection against atrial fibrillation-related thromboembolic events in elderly adults.
This review provides a comprehensive overview of the risks, benefits, and barriers to oral anticoagulation in elderly patients with atrial fibrillation, integrating newer agents with established therapies.
No takes yet. Share an insight, caveat, or question.
Supports anticoagulation consideration in elderly AF; leaves open optimal agent choice and bleeding management in frail subgroups.
Zarraga et al. (2012) conducted a review in Atrial fibrillation. Oral anticoagulation was evaluated. Oral anticoagulation, including warfarin and new oral anticoagulants, offers significant protection against atrial fibrillation-related thromboembolic events in elderly adults.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: